Tyler Van Buren

Work

Analyst Tyler Van Buren works at COWEN and is focused on the Healthcare sector with 538 price targets and ratings documented since 2017 spanning on 42 stocks. Previously, Tyler Van Buren worked at PIPER SANDLER. Analyst's average stock valuation to be materialised ratio is 42.73% with an average time for price targets to be met of 149.97 days.

Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals, Inc at 30-Jan-2023.

Tyler Van Buren best performing recommendations are on RCKT (ROCKET PHARMACEUTICALS, INC).
The best stock recommendation documented was for RCKT (ROCKET PHARMACEUTICALS, INC) at 12/8/2020. The price target of $50 was fulfilled within 1 day with a profit of $17.97 (56.1%) receiving and performance score of 561.04.

Average potential price target upside

ADVM AGIO ALLO APTO BGNE BHVN BLUE GILD GOSS HARP INCY IONS MRNA MRTX NKTR OTIC RCKT SRPT AERI ARVN REGN TBPH BBIO BCRX CRNX FATE KURA MGTX NRIX OVID OYST PRAX PTE CRSP NEOS TPTX CBAY CBIO LPTX ALGS DCPH PSTX

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

2

$1.3 (185.71%)

2.5

2 months 26 days ago

0/2 (0%)

$1.13 (114.91%)

Hold

2

$1.3 (185.71%)

5

1 years 6 months 14 days ago

3/5 (60%)

$3.07 (29.73%)

47

Hold

3

$2.3 (328.57%)

21

1 years 6 months 14 days ago

4/5 (80%)

$3.63 (50.89%)

139

Hold

21

1 years 6 months 14 days ago

2/2 (100%)

$7.53 (88.83%)

197

Buy

6

$5.3 (757.14%)

30

1 years 9 months 8 days ago

1/3 (33.33%)

$4.81 (39.30%)

34

Show more analysts
ADVM AGIO ALLO APTO BGNE BHVN BLUE GILD GOSS HARP INCY IONS MRNA MRTX NKTR OTIC RCKT SRPT AERI ARVN REGN TBPH BBIO BCRX CRNX FATE KURA MGTX NRIX OVID OYST PRAX PTE CRSP NEOS TPTX CBAY CBIO LPTX ALGS DCPH PSTX